Uploaded May 2026 | Updated November 2026, 1 day ago
Can a life-saving stem cell transplant be done without chemotherapy or radiation?
At Stanford Medicine, scientists are pioneering a new antibody-based approach for Fanconi anemia—a rare condition that causes bone marrow failure and increases cancer risk over time.
Built on decades of discovery, this method replaces traditional toxic conditioning with a targeted therapy that safely makes room for healthy donor cells. The goal: restore blood and immune function while reducing long-term harm.
Early clinical results are promising—bringing safer stem cell transplants without chemotherapy or radiation closer to reality, and opening new possibilities for treating rare genetic diseases.
Learn more about this research:
https://stan.md/4mYUIEa
https://stan.md/4ebOA9d
This work is led by Stanford Medicine researchers in collaboration with:
Stanford Institute for Stem Cell Biology and Regenerative Medicine: https://stemcell.stanford.edu
Center for Definitive and Curative Medicine: https://cdcm.stanford.edu
Lucile Packard Children’s Hospital Stanford: stanfordchildrens.org
Bass Center for Childhood Cancer and Blood Diseases: stanfordchildrens.org/en/service/cancer
#FanconiAnemia #RareDisease #StanfordMedicine
.
.
.
Stanford Medicine advances human health through world-class biomedical research, education and patient care. Bringing together the resources of Stanford University School of Medicine, Stanford Health Care and Lucile Packard Children's Hospital, Stanford Medicine is committed to training future leaders in biomedicine and translating the latest discoveries into new ways to prevent, diagnose and treat disease.
The Stanford Medicine YouTube channel is a curated collection of contributions from our School of Medicine departments, divisions, students, and the community. Our diverse content includes coverage of events, presentations, lectures, and associated stories about the people of Stanford Medicine.
Can a life-saving stem cell transplant be done without chemotherapy or radiation?
At Stanford Medicine, scientists are pioneering a new antibody-based approach for Fanconi anemia—a rare condition that causes bone marrow failure and increases cancer risk over time.
Built on decades of discovery, this method replaces traditional toxic conditioning with a targeted therapy that safely makes room for healthy donor cells. The goal: restore blood and immune function while reducing long-term harm.
Early clinical results are promising—bringing safer stem cell transplants without chemotherapy or radiation closer to reality, and opening new possibilities for treating rare genetic diseases.
Learn more about this research:
https://stan.md/4mYUIEa
https://stan.md/4ebOA9d
This work is led by Stanford Medicine researchers in collaboration with:
Stanford Institute for Stem Cell Biology and Regenerative Medicine: https://stemcell.stanford.edu
Center for Definitive and Curative Medicine: https://cdcm.stanford.edu
Lucile Packard Children’s Hospital Stanford: stanfordchildrens.org
Bass Center for Childhood Cancer and Blood Diseases: stanfordchildrens.org/en/service/cancer
#FanconiAnemia #RareDisease #StanfordMedicine
.
.
.
Stanford Medicine advances human health through world-class biomedical research, education and patient care. Bringing together the resources of Stanford University School of Medicine, Stanford Health Care and Lucile Packard Children's Hospital, Stanford Medicine is committed to training future leaders in biomedicine and translating the latest discoveries into new ways to prevent, diagnose and treat disease.
The Stanford Medicine YouTube channel is a curated collection of contributions from our School of Medicine departments, divisions, students, and the community. Our diverse content includes coverage of events, presentations, lectures, and associated stories about the people of Stanford Medicine.










